Interferon-gamma release assay on suspicion of active tuberculosis;Interferon-gamma release-assay ved mistanke om aktiv tuberkulose?

Ugeskrift for Laeger

Volumn 171, Issue 37, 2009, Pages 2631-2635

  Browatzki, Andrea ^a   Meyer, Christian Niels ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON;

ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST;

BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; INTERFERON-GAMMA; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 70349305274     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dahl R, Bæk K, Iversen MP et al. Tuberkulose - en praktisk vejledning. Diagnostik, behandling og miljøundersøgelse. København: Den Almindelige Danske Lægeforening 2000:1-8.
2. Kok-Jensen A, Pedersen JT, Taudorf E et al. Det Nationale Tuberkuloseprogram og forslag til klinisk håndtering af TB. København: Den Almindelige Danske Lægeforening 2000:1-20.
3. National Institute for Health and Clinical Excellence. Clinical Guideline 33. Tuberculosis. Clinical diagnosis and management of tuberculosis, and Measures for its Prevention and Control. www.nice.org.uk/CG033 2006 (21. oktober 2008).
4. Raviglione Mario C, O'Brien Richard J, »Chapter 158. Tuberculosis"(Chapter). Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J: Harrison's Principles of Internal Medicine, 17th Edition. www.accessmedicine.com.ep.fjernadgang.kb.dk/content.aspx?aID=28951070? (21. oktober 2008).
5. Seersholm N, Seefeldt T, Andersen LS et al. Retningslinjer for undersøgelse for latent og aktiv tuberkulose forud for behandling med TNF-a hæmmere. www.lungemedicin.dk/guidelines/tb-tnf-alfa-final.pdf (21.oktober 2008).
6. Mazurek GH, Weis SE, Moonan PK et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-g release assays in the persons with suspected tuberculosis. CID 2007;45:837-45.
7. Diel R, Forssbohm M, Loytved G et al. [Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis]. Gesundheitswesen 2007;69:488-503.
8. Braendli O, Desgrandchamps D et al. Handbuch Tuberkulose. Swiss Lung League. Bundesamt für Gesundheit 2007. 1-80.
9. www.tbinfo.ch/uploads/media/Handbuch_Tuberkulose_d_140507.pdf (21. oktober 2008).
10. Ravn P, Munk ME, Andersen AB et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005;12:491-6.
11. Mazurek GH, Jereb J, Lobue P et al. Guidelines for using the QuantiFERON-TB gold test for detecting mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54:49-55.
12. TUBERCULOSIS. Clinical diagnosis and Management of tuberculosis, and measures for its prevention. London: Royal College of Physicians. 2006. www.rcplondon.ac.uk/pubs/contents/dfb1d46a-bc32-4538-b631-1d82f4b6c8aa.pdf (21. oktober 2008).
13. Rud B, Matzen P, Hilden J. Mål for diagnostiske tests ydeevne. Ugeskr Læger 2005;167:3018-22.
14. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-54.
15. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004;170:59-64.
16. Pathan AA, Wilkinson KA, Klenerman P et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001;167:5217-25.
17. Moran-Mendoza O, Marion SA, Elwood K et al. Tuberculin skin test size and risk of tuberculosis development: a large population-based study in contacts. Int J Tuberc Lung Dis 2007;11:1014-20.
18. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007;11:593-605.
19. Ewer K, Deeks J, Alvarez L et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168-73.
20. Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007;131:1424-34.